Evidence map›Paper›PMID 38676478›Full record

ReviewCurrent drug safety2025

From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy.

Arzoo Pannu, Ramesh K Goyal

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Lanzhou Lily (Food science & nutrition · 2026
    Article
  2. Diet-Dependent Chemical Profiling and Bioactivity ofMolecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Frontiers in nutrition · 2026
    Article
  6. Review
  7. Article
  8. Antidepressant Potential of Hispidulin Present inCentral nervous system agents in medicinal chemistry · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arzoo PannuDepartment of Pharmacology, Delhi Pharmaceutical Sciences & Research University, Delhi, 110017, India.
Ramesh K GoyalDepartment of Pharmacology, Delhi Pharmaceutical Sciences & Research University, Delhi, 110017, India.

Funding

Department of Science and Technology, Ministry of Science and Technology, India IF 170821, 2017
6 · The paper itself

Abstract

Depression, a pervasive mental health disorder, affects millions worldwide, necessitating the widespread use of synthetic anti-depressant medications. While these pharmaceutical interventions have demonstrated efficacy in alleviating depressive symptoms, they are not without their associated side effects. This review provides a comprehensive overview of the side effects of synthetic anti-depressants, aiming to enhance the understanding of their clinical implications. Common side effects explored include gastrointestinal disturbances, sexual dysfunction, insomnia, weight gain, and cognitive impairments. Additionally, this review delves into less frequent but potentially severe adverse events, such as serotonin syndrome, hyponatremia, and cardiac complications associated with specific classes of synthetic anti-depressants. Moreover, the review examines the interplay between side effects and treatment adherence, emphasizing the importance of monitoring and managing these effects in clinical practice. It also discusses strategies to mitigate side effects, including dose adjustments, combination therapy, and alternative treatment approaches. In conclusion, this comprehensive review sheds light on the multifaceted landscape of side effects associated with synthetic anti-depressants. By providing clinicians with a nuanced understanding of these effects, it aims to facilitate informed decision-making, personalized treatment plans, and improved patient outcomes in managing depression.

Indexed as

Antidepressive AgentsDepressionDepressive DisorderHumansAntidepressive AgentsAntidepressant medicationsclinical implicationspharmacogeneticsside-effectstreatment strategiestricyclic antidepressants (TCAs).

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.